Midatech Pharma PLC Holding(s) in Company (1324O)
November 02 2016 - 5:51AM
UK Regulatory
TIDMMTPH
RNS Number : 1324O
Midatech Pharma PLC
02 November 2016
For filings with the FCA
include the annex
For filings with issuer exclude
the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------------------------------------
1. Identity of the issuer or MIDATECH PHARMA PLC
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
------------------------------------------------------ ------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
--------------------------------------------------------------------------------
An acquisition or disposal of voting rights ü
------------------------------------------------------- -----------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
------------------------------------------------------- -----------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
------------------------------------------------------- -----------------------
An event changing the breakdown of voting rights ü
------------------------------------------------------- -----------------------
Other (please
specify):
----------------------------------------------------- -----------------------
3. Full name of person(s) HARGREAVE HALE LIMITED
subject to the
notification obligation:
(iii)
------------------------------------------------------ ------------------------
4. Full name of shareholder(s) DISCRETIONARY CLIENTS
(if different from 3.):(iv)
------------------------------------------------------ ------------------------
5. Date of the transaction 31 OCTOBER 2016
and date on
which the threshold is
crossed or
reached: (v)
------------------------------------------------------ ------------------------
6. Date on which issuer 01 NOVEMBER 2016
notified:
------------------------------------------------------ ------------------------
7. Threshold(s) that is/are
crossed or
reached: (vi, vii) 5%
------------------------------------------------------ ------------------------
8. Notified details:
-----------------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
-----------------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the triggering
of to the triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- --------------------------------- ---------------------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
------------- --------------- ---------------- ----------------------------- ----------------------- -------------------
Direct Indirect Direct Indirect Direct Indirect
(xi) (xii)
------------- ----------- ------------ ------------- -------------- --------- ------------ -------- ---------
GB00BRTL9B63 1,431,086 1,431,086 2,484,211 2,484,211 5.1011%
--------------- ---------------- ------------- -------------- --------- ------------ -------- ---------
B: Qualifying Financial Instruments
-----------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
----------------- --------------- ------------------------------- ----------------------------------- -------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
-----------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
--------------- --------------- ---------------- ------------- ------------------------- -------------------------------
Nominal Delta
--------------- --------------- ---------------- ------------- ------------------------- -------------------- ---------
Total (A+B+C)
-----------------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
----------------------------------------------------------------- ----------------------------------------------------------
2,484,211 5.1011%
----------------------------------------------------------------- ----------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
-------------------------------------------------------------------------------------------------------
2,253,125 of these shares are held for a unit trust
operated by Marlborough Fund Managers Ltd, for whom
Hargreave Hale Ltd manages the investments on a discretionary
basis. The remaining shares are held for other discretionary
clients.
Proxy Voting:
-------------------------------------------------------------------------------------------------------
10. Name of the proxy holder:
---------------------------------------------------------------- -------------------------------------
11. Number of voting rights proxy
holder will cease
to hold:
---------------------------------------------------------------- -------------------------------------
12. Date on which proxy holder will
cease to hold
voting rights:
---------------------------------------------------------------- -------------------------------------
The change in the percentage
13. Additional information: of shares held is entirely
due to participation in the
open offer by Midatech Pharma
Plc, the shares from which
were admitted to AIM on 31/10/2016.
---------------------------------------------------------------- -------------------------------------
14. Contact name: David Clueit,
Hargreave Hale Ltd
---------------------------------------------------------------- -------------------------------------
15. Contact telephone number: 01253 754739
---------------------------------------------------------------- -------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLBTBLTMBIMMLF
(END) Dow Jones Newswires
November 02, 2016 05:51 ET (09:51 GMT)
Midatech Pharma (LSE:MTPH)
Historical Stock Chart
From Apr 2024 to May 2024
Midatech Pharma (LSE:MTPH)
Historical Stock Chart
From May 2023 to May 2024